BML (BMLKF) ROE % Adjusted to Book Value: 3.19% (As of Mar. 2026)

BML BMLKF 73 ROE % Adjusted to Book Value is 3.19% as of Mar. 2026. GuruFocus rates BMLKF with a GF Score™ of 73/100 and a GF Value™ of $26.44. The stock has 2 warning signs investors should review.

BML's ROE % for the quarter that ended in Mar. 2026 was 3.73%. BML's PB Ratio for the quarter that ended in Mar. 2026 was 1.17. BML's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 3.19%.

BML ROE % Adjusted to Book Value Related Terms

BML ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for BML's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML ROE % Adjusted to Book Value Chart

BML Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

61.02

22.76

7.78

5.41

4.99

BML Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															3.48	6.60	8.14	7.70	3.19

BMLKF vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, BML's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BML ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BML's ROE % Adjusted to Book Value falls into.

Save Embed

73GF Score

BML Inc BMLKF

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BML ROE % Adjusted to Book Value Calculation

BML's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.84%	/	1.17
	=	4.99%

BML's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	3.73%	/	1.17
	=	3.19%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 3.19% mean?

BML (BMLKF) has a ROE % Adjusted to Book Value of 3.19% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BML and its competitors.

Is BML's ROE % Adjusted to Book Value too high?

BML's current ROE % Adjusted to Book Value is 3.19%. Overall, BML has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.

How does BML's ROE % Adjusted to Book Value compare to TMO and DHR?

BML's ROE % Adjusted to Book Value of 3.19% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?

A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BML and its competitors. BML's current ROE % Adjusted to Book Value is 3.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BML stock overvalued right now?

BML (BMLKF) has a current ROE % Adjusted to Book Value of 3.19%. The stock's GF Value™ is $26.44, compared to a current price of $25.21 — trading 4.7% below its estimated fair value. The current ROE % Adjusted to Book Value is 3.19%. BML's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For BML (BMLKF), the current ROE % Adjusted to Book Value is 3.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BML (BMLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BML stock appears to be undervalued. The current stock price of $25.21 is trading 4.7% below its estimated GF Value™ of $26.44.

Key valuation signals for BMLKF:

ROE % Adjusted to Book Value: 3.19%
GF Value™: $26.44 vs. price of $25.21 (4.7% below fair value)
GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BML Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TSE:4544 TSE:2395 TSE:4671 TSE:3386 TSE:6090 TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH MEDP

Other Exchanges 4694:Japan

Address 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051

Website http://www.bml.co.jp

BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.

73GF Score

Get the complete analysis for BMLKF

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.21

Price

$26.44

GF Value

View BMLKF Analysis

See ROE % Adjusted to Book Value data for all stocks →